NCT00657046View on ClinicalTrials.gov

Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Intradialytic Hypotension
Interventions
DRUG

Droxidopa

Capsules containing 200 mg droxidopa

DRUG

Placebo

Capsules with mannitol substituted for droxidopa

Trial Locations (1)

97504

Rogue Valley Dialysis, Medford

Sponsors
All Listed Sponsors
lead

Chelsea Therapeutics

INDUSTRY